Corvus Pharmaceuticals (CRVS) Net Income (2015 - 2026)
Corvus Pharmaceuticals' Net Income came in at -$17.25 million for Q2 2026, compared with -$7.61 million a year earlier.
Powered by 
Analysis
Corvus Pharmaceuticals (CRVS) Net Income (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Corvus Pharmaceuticals reported Net Income of -$47.79 million; for FY2023, it was -$21.82 million.
- Going back by year, Net Income was -$31.91 million in FY2022, -$38.65 million in FY2021, -$43.22 million in FY2020 and -$46.67 million in FY2019.
- The Q2 2026 figure represents the lowest quarterly Net Income since Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.62 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.51 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -237.00 Mn |
| 10 | Corvus Pharmaceuticals | 916.92 Mn | 405.36 Mn | - | -17.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -17.25 Mn |
| Mar 31, 2026 | -13.09 Mn |
| Sep 30, 2025 | -9.83 Mn |
| Jun 30, 2025 | -7.61 Mn |
| Mar 31, 2025 | 15.73 Mn |
| Sep 30, 2024 | -39.54 Mn |
| Jun 30, 2024 | -3.69 Mn |
| Mar 31, 2024 | -5.94 Mn |
| Dec 31, 2023 | -5.27 Mn |
| Sep 30, 2023 | -5.14 Mn |
| Jun 30, 2023 | -5.22 Mn |
| Mar 31, 2023 | -6.14 Mn |
| Dec 31, 2022 | -5.35 Mn |
| Sep 30, 2022 | -12.25 Mn |
| Jun 30, 2022 | -6.91 Mn |
| Mar 31, 2022 | -7.40 Mn |
| Dec 31, 2021 | -6.82 Mn |
| Sep 30, 2021 | -9.06 Mn |
| Jun 30, 2021 | -11.29 Mn |
| Mar 31, 2021 | -11.48 Mn |
API Access
Corvus Pharmaceuticals Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=CRVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "CRVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=CRVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();